Company News
Lonza appoints Juan Andres and Eric Drapé to its Board as independent members
Lonza appoints Juan Andres and Eric Drapé to its Board as independent members
The two bring a wealth of pharmaceutical knowledge, and have worked in a number of leadership positions at pharma giants such as Novo Nordisk, Moderna and Eli Lilly
Steve Becker joins Broken String Biosciences as Chief Commercial Officer
Steve Becker joins Broken String Biosciences as Chief Commercial Officer
Steve's will help to push the company's INDUCE-seq commercialisation strategy forward
Metrion Biosciences appoints Dr Chris Mathes as Chief Commercial Officer
Metrion Biosciences appoints Dr Chris Mathes as Chief Commercial Officer
Chris' appointment will assist the company in making its commercial growth plans a reality
Optibrium appoints James Halle as Chief Commercial Officer
Optibrium appoints James Halle as Chief Commercial Officer
James will assist the company in commercialising StarDrop, Cerella and Semeta, the company's proprietary drug development platforms
Cherwell appoints Andy Charteris as new Director of Operations
Cherwell appoints Andy Charteris as new Director of Operations
Andy will assist Cherwell in its plans to acceleration its growth in the cleanroom space
Vivet Therapeutics’ Dr Gloria Gonzalez-Aseguinolaza receives the Rosalind Franklin Society Special Award in Science
Vivet Therapeutics’ Dr Gloria Gonzalez-Aseguinolaza receives the Rosalind Franklin Society Special Award in Science
The award was appointed to Dr Gloria Gonzalez-Aseguinolaza for her work in advancing cell and gene therapies
Mogrify appoints Dr Jonathan Appleby as Chief Scientific Officer
Mogrify appoints Dr Jonathan Appleby as Chief Scientific Officer
Dr Appleby has extensive experience in the development and commercialisation of both conventional and advanced therapeutics
Cellular Origins appoints Geoffrey Hodge as Non-Executive Director
Cellular Origins appoints Geoffrey Hodge as Non-Executive Director
Geoff will contribute to the company's commercial growth efforts while also shaping the future direction of Cellular Origins
Quell Therapeutics Appoints Experienced Biopharma Leader Luke Beshar as Independent Chair of its Board of Directors
Quell Therapeutics Appoints Experienced Biopharma Leader Luke Beshar as Independent Chair of its Board of Directors
Luke brings more than 35 years of experience to the role, and has been non-executive director of a range of large biopharmaceutical companies
etherna appoints Antonin de Fougerolles as new Chairperson
etherna appoints Antonin de Fougerolles as new Chairperson
Tony has extensive experience in the development of novel therapeutic modalities, such as RNAis and modified mRNAs for vaccinations
Selkirk Pharma appoints Colleen Dixon as CEO
Selkirk Pharma appoints Colleen Dixon as CEO
Colleen has more than 30 years of experience in the pharmaceutical industry, and will succeed Patrick Haffey
Newcells Biotech appoints Emile Shaffu as Director of Sales
Newcells Biotech appoints Emile Shaffu as Director of Sales
Emile will work with Newcells to expand its global presence, as well as boost its customer service capabilities
H.E.L Group appoints Yih-Shing Duh as Chief Scientific Advisor
H.E.L Group appoints Yih-Shing Duh as Chief Scientific Advisor
Prof. Duh will continue to assist H.E.L Group in developing its battery calorimeters and lithium ion battery testing protocols
Lonza appoints Wolfgang Wienand as the group’s CEO
Lonza appoints Wolfgang Wienand as the group’s CEO
Wolfgang will lead Lonza as the CDMO continues to push its growth and customer satisfaction
Marchesini Group appoints President Maurizio Marchesini as CEO
Marchesini Group appoints President Maurizio Marchesini as CEO
President Marchesini will focus on investing in technological advances in pharmaceutical manufacturing, as well as globalisation for the group
Asymchem appoints Dr Cheng Yi Chen as CTO of Small Molecules
Asymchem appoints Dr Cheng Yi Chen as CTO of Small Molecules
He will support the group's small molecule sales and offer technical guidance to laboratories and pilot production sites across Europe
CN Bio appoints Lydia Seymour as VP of People and Culture
CN Bio appoints Lydia Seymour as VP of People and Culture
Lydia will work to enhance the company's workplace culture, whilst also supporting the career development and general wellbeing of employees
Actylis appoints Scott Thomson as CEO
Actylis appoints Scott Thomson as CEO
Scott will endeavour to globally expand the company's integrated manufacturing and sourcing strategy
Enterprise Therapeutics appoints new as Chief Medical Officer and Non-Executive Director
Enterprise Therapeutics appoints new as Chief Medical Officer and Non-Executive Director
The appointments will help push the company's lead asset through Phase II trials
Onyx Scientific aims for European growth with new BD hire
Onyx Scientific aims for European growth with new BD hire
Leading small molecule CDMO Onyx Scientific has its sights set on European-wide commercial expansion with the new appointment of Courtnie Thomas Wilks as Business Development...
AES Clean Technology appoints Chris Miller as CEO
AES Clean Technology appoints Chris Miller as CEO
Miller will champion the company’s growth whilst encouraging the development of industry innovations
Asymchem hires Franck Mevellec as Senior Director of business development
Asymchem hires Franck Mevellec as Senior Director of business development
Franck has more than 20 years of industry experience, holding key positions in sales, R&D and portfolio management
Exonate appoints Dr Rafiq Hasan as Non-Executive Director
Exonate appoints Dr Rafiq Hasan as Non-Executive Director
Dr Hasan will assist the company in developing its lead candidate, as well as strengthening its commercial strategy
Rentschler Biopharma appoints Patrick Meyer as Global Head BD Sales and Alliance Management
Rentschler Biopharma appoints Patrick Meyer as Global Head BD Sales and Alliance Management
Rentschler Biopharma SE announces that Patrick Meyer, Ph.D., has been promoted to Global Head BD Sales and Alliance Management within the business development team, effective...